Reporting owner · CIK 0001352090
Kurzius Lawrence Erik
Visual SEC Form 4 history across 2 companies, 15 transactions and 8 filings.
DIRElanco Animal Health Inc
Open-market mix
25%buys
Open-market buy performance
90-day forward return on this insider's open-market purchases
For every open-market buy (Form 4 code P, acquisition A) in the selected window, we take the closing price on the transaction date and 90 calendar days later, then compute the percentage change. The figures shown are the simple average and median of those per-buy returns.
- Window follows the rest of the summary (all-history or last 3 months).
- Only buys with a resolved price context are counted.
- Includes both positive and negative outcomes; gains and losses net out at the per-buy level.
Monthly open-market activity
Reported purchase and sale transaction counts
Buys Sells
Net value flow
Buys minus sells
Dec 23
$0
Dec 24
$0
Jan 25
$0
Feb 25
−$3.8M
Jan 26
−$3.4M
Feb 26
−$3.6M
Aug 26
$935.9K
Transaction texture
Ownership and ticket size
Average P/S size$2.9M
Median P/S size$3.5M
Direct14
Indirect1
Aug 20, 2026buy
Filing-only signals
Deterministic matches in this insider's history
Latest Form 4 facts
Quick context from source filings
Latest transaction
buy at Elanco Animal Health Inc on Aug 20, 2026 valued at $935,920.
Review SEC filingAssociated companies
Visual map of known reporting history
| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| ELAN | Kurzius Lawrence Erik | DIR | buy | 40.0k | $93.5M | P | +0.6% | 08/21 | 08/20 | |
| MKC | Kurzius Lawrence Erik | 10% | exercise | 50.0k | $0 | M | −34.9% | 02/13 | 02/12 | |
| MKC | Kurzius Lawrence Erik | 10% | sale | 50.0k | -$358M | S | −34.9% | 02/13 | 02/12 | |
| MKC | Kurzius Lawrence Erik | 10% | exercise | 50.0k | $245M | M | −34.9% | 02/13 | 02/12 | |
| MKC | Kurzius Lawrence Erik | 10% | exercise | 50.0k | — | M | — | 01/14 | 01/13 | |
| MKC | Kurzius Lawrence Erik | 10% | sale | 50.0k | -$337M | S | — | 01/14 | 01/13 | |
| MKC | Kurzius Lawrence Erik | 10% | exercise | 50.0k | $249M | M | — | 01/14 | 01/13 | |
| MKC | Kurzius Lawrence Erik | DIR | withholding | 30.5k | -$235M | F | — | 02/20/2025 | 02/18/2025 | |
| MKC | Kurzius Lawrence Erik | DIR | exercise | 50.0k | $0 | M | — | 02/04/2025 | 02/03/2025 | |
| MKC | Kurzius Lawrence Erik | DIR | sale | 50.0k | -$384M | S | — | 02/04/2025 | 02/03/2025 |
Kurzius Lawrence Erik Insider Activity FAQ
SEC Form 4 context
Who is Kurzius Lawrence Erik?
Kurzius Lawrence Erik is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001352090.
Which companies has Kurzius Lawrence Erik reported transactions for?
Elanco Animal Health Inc, MCCORMICK & CO INC
When was Kurzius Lawrence Erik's latest insider buy?
buy at Elanco Animal Health Inc on Aug 20, 2026 valued at $935,920.
When was Kurzius Lawrence Erik's latest insider sale?
sale at MCCORMICK & CO INC on Feb 12, 2026 valued at $3,581,500.
Where can I see the original SEC filings?
Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.
Are performance metrics included?
This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.